Minor triple yang liver disease is often referred to as hepatitis B minor triple yang, which usually requires patients to confirm the extent of liver damage based on other tests to determine whether the disease is serious. In most cases, Hepatitis B minor triple positive means that the virus has stopped replicating or is at a low level of replication, is not infectious or less infectious, and the patient’s liver function is normal, which is usually not serious. However, some patients with Hepatitis B minor triple positive may still be highly infectious and have abnormal liver function, which is more serious and requires systematic antiviral treatment. Hepatitis B minor triple Yang patients may show symptoms such as decreased appetite, fatigue, low fever, muscle or joint pain, nausea, vomiting, abdominal pain, etc. Some patients may have liver function damage, which requires timely liver ultrasound, liver function blood tests, etc. If the patient is in the acute stage, bed rest is usually needed to improve symptoms and reduce liver damage. If the patient is in the chronic stage, antiviral treatment is usually needed to improve the immune function of the body, protect the liver cells and anti-hepatic fibrosis, etc. to protect the liver function from being affected. For living items such as razors and toothbrushes, it is recommended that patients with SCT and their family members use them separately to avoid cross-infection. However, in daily contact, shaking hands, hugging, sharing toilets and other non-blood exposure contacts, there is basically no possibility of transmission.